Stronger cholesterol medicine saves more lives
Review: More-intensive vs less-intensive LDL-cholesterol lowering reduces mortality
Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms
Surprising Findings
No survival benefit in patients with baseline LDL-C <100 mg/dL
Many assume lower cholesterol is always better, but this study shows no reduction in death rates for people who already start with relatively low LDL.
Practical Takeaways
If you have heart disease or high cardiovascular risk and your LDL-C is 100 mg/dL or higher, talk to your doctor about more intensive cholesterol-lowering therapy.
Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms
Surprising Findings
No survival benefit in patients with baseline LDL-C <100 mg/dL
Many assume lower cholesterol is always better, but this study shows no reduction in death rates for people who already start with relatively low LDL.
Practical Takeaways
If you have heart disease or high cardiovascular risk and your LDL-C is 100 mg/dL or higher, talk to your doctor about more intensive cholesterol-lowering therapy.
Publication
Related Content
Claims (4)
If you've had heart problems before, aiming to get your 'bad' cholesterol really low—below 55—cuts your risk of another heart issue by about a third compared to keeping it just under 70.
If you have high 'bad' cholesterol, lowering it more aggressively can help you live longer, especially if your levels are really high to begin with. Doctors should decide how hard to treat based on how high your cholesterol is and your overall heart risk.
Taking stronger treatments to lower bad cholesterol seems to cut the risk of heart attacks, strokes, and other serious heart problems — even if your cholesterol isn’t that high to begin with.
If your 'bad' cholesterol is 100 or higher, lowering it more aggressively helps prevent heart-related deaths. But if it's already below 100, lowering it even more doesn't seem to help much — there might be a cutoff where treatment stops adding extra benefit.